Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study

By sjmartinez • July 13, 2024

Narasaki Y, Kovesdy CP, You AS, Sumida K, Mallisetty Y, Surbhi S, Thomas F, Amin AN, Streja E, Kalantar-Zadeh K, Rhee CM. Safety of SGLT2 inhibitors, DPP-4 inhibitors, and GLP-1 receptor agonists in US veterans with and without chronic kidney disease: a population-based study. Lancet Reg Health Am. 2024 Jun 18;36:100814. doi: 10.1016/j.lana.2024.100814. PMID: 38993538; PMCID: PMC11237921.

Tags: Harbor UCLA, Nephrology, Publications, Veterans Administration

Immune system benefits of pulmonary rehabilitation in chronic obstructive pulmonary disease

Abbasi A, Wang D, Stringer WW, Casaburi R, Rossiter HB. Immune system benefits of pulmonary rehabilitation in chronic obstructive pulmonary disease. Exp Physiol. 2024 Oct[...]

Relationship of Plasma Apolipoprotein C-I Truncation With Risk of Diabetes in the Multi-Ethnic Study of Atherosclerosis and the Actos Now for the Prevention of Diabetes Study

Koska J, Hu Y, Furtado J, Billheimer D, Nedelkov D, Schwenke D, Budoff MJ, Bertoni AG, McClelland RL, Reaven PD. Relationship of Plasma Apolipoprotein C-I[...]

Quality measures in the delivery of equitable endoscopic care to traditionally underserved patients in the United States

ASGE Quality Assurance in Endoscopy Committee; Williams KN, May FP, Cummings LC, Srivastava N, Shahidi N, Kohansal A, Panganamamula K, Garg R, Singh A, Green[...]